Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana
Microbiology Spectrum · 2023
DOI: 10.1128/spectrum.04916-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Yaw Aniweh und 11 weiteren Autor:innen. Beteiligte Einrichtung: West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Ghana. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium ovale, Malaria, Malaria, Falciparum. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Department of Health, Wellcome Trust.
Abstract (Originalsprache)
Current malaria control and elimination tools such as drug treatments are not specifically targeting P.ovale . P. ovale can form hypnozoite and cause relapsing malaria. P. ovale is the third most dominant species in Africa and requires radical cure treatment given that it can form liver dormant forms called hypnozoites that escape all safe treatments. The inappropriate treatment of P. ovale would sustain its transmission in Africa where the medical need is the greatest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Ghana.
- Malaria Research and Training Centre (MRTC), Faculty of Pharmacy, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Point G, Bamako, Mali.
- Medicines for Malaria Venture (MMV), Geneva, Switzerland.
ORCID-Profile: Yaw Aniweh, Laurent Dembele
Förderung
- Medical Research Council
- Department of Health
- Wellcome Trust
- Cancer Research UK
- Bill & Melinda Gates Foundation
- EC | H2020 | ERA-LEARN | European and Developing Countries Clinical Trials Partnership
Zitieren
APA
Aniweh, Y., Soulama, A., Chirawurah, J., Ansah, F., Danwonno, H. A., Sogore, F., Rouillier, M., Campo, B., Amenga-Etego, L., Djimde, A. A., Awandare, G. A., & Dembele, L. (2023). Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04916-22
Vancouver
Aniweh Y, Soulama A, Chirawurah J, Ansah F, Danwonno HA, Sogore F, et al. Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana. Microbiology Spectrum. 2023. doi:10.1128/spectrum.04916-22
BibTeX
@article{Aniweh2023,
author = {Aniweh, Yaw and Soulama, Alamissa and Chirawurah, Jersley and Ansah, Felix and Danwonno, Harry A and Sogore, Fanta and Rouillier, Melanie and Campo, Brice and Amenga-Etego, Lucas and Djimde, Abdoulaye A and Awandare, Gordon A and Dembele, Laurent},
title = {Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana},
journal = {Microbiology Spectrum},
year = {2023},
doi = {10.1128/spectrum.04916-22}
}
EUVIMED